Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB3551 - Provider product page
- Provider
- R&D Systems
- Product name
- Anti-Human BMP-2 Monoclonal Antibody (Clone 100221)
- Antibody type
- Monoclonal
- Antigen
- Chinese hamster ovary cell line CHO-derived recombinant human BMP-2, Gln283-Arg396
- Description
- Protein A or G purified from ascites
- Reactivity
- Human
- Host
- Mouse
- Antigen sequence
P12643
- Isotype
- IgG
- Vial size
- 500 µg
Submitted references TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling.
Osteogenic Surface Modification Based on Functionalized Poly-P-Xylylene Coating.
Regulation of retinal progenitor cell differentiation by bone morphogenetic protein 4 is mediated by the smad/id cascade.
Periodontal regeneration using ex vivo autologous stem cells engineered to express the BMP-2 gene: an alternative to alveolaplasty.
Targeting of bone morphogenetic protein growth factor complexes to fibrillin.
Chordin-like 1, a bone morphogenetic protein-4 antagonist, is upregulated by hypoxia in human retinal pericytes and plays a role in regulating angiogenesis.
Selective binding of RGMc/hemojuvelin, a key protein in systemic iron metabolism, to BMP-2 and neogenin.
Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.
Indian hedgehog signaling pathway: expression and regulation in pancreatic cancer.
Hurst LA, Dunmore BJ, Long L, Crosby A, Al-Lamki R, Deighton J, Southwood M, Yang X, Nikolic MZ, Herrera B, Inman GJ, Bradley JR, Rana AA, Upton PD, Morrell NW
Nature communications 2017 Jan 13;8:14079
Nature communications 2017 Jan 13;8:14079
Osteogenic Surface Modification Based on Functionalized Poly-P-Xylylene Coating.
Chang CH, Yeh SY, Lee BH, Chen CJ, Su CT, Lin YT, Liu CL, Chen HY
PloS one 2015;10(9):e0137017
PloS one 2015;10(9):e0137017
Regulation of retinal progenitor cell differentiation by bone morphogenetic protein 4 is mediated by the smad/id cascade.
Du Y, Xiao Q, Yip HK
Investigative ophthalmology & visual science 2010 Jul;51(7):3764-73
Investigative ophthalmology & visual science 2010 Jul;51(7):3764-73
Periodontal regeneration using ex vivo autologous stem cells engineered to express the BMP-2 gene: an alternative to alveolaplasty.
Chen YL, Chen PK, Jeng LB, Huang CS, Yang LC, Chung HY, Chang SC
Gene therapy 2008 Nov;15(22):1469-77
Gene therapy 2008 Nov;15(22):1469-77
Targeting of bone morphogenetic protein growth factor complexes to fibrillin.
Sengle G, Charbonneau NL, Ono RN, Sasaki T, Alvarez J, Keene DR, Bächinger HP, Sakai LY
The Journal of biological chemistry 2008 May 16;283(20):13874-88
The Journal of biological chemistry 2008 May 16;283(20):13874-88
Chordin-like 1, a bone morphogenetic protein-4 antagonist, is upregulated by hypoxia in human retinal pericytes and plays a role in regulating angiogenesis.
Kane R, Godson C, O'Brien C
Molecular vision 2008 Jun 20;14:1138-48
Molecular vision 2008 Jun 20;14:1138-48
Selective binding of RGMc/hemojuvelin, a key protein in systemic iron metabolism, to BMP-2 and neogenin.
Kuns-Hashimoto R, Kuninger D, Nili M, Rotwein P
American journal of physiology. Cell physiology 2008 Apr;294(4):C994-C1003
American journal of physiology. Cell physiology 2008 Apr;294(4):C994-C1003
Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.
Dai J, Keller J, Zhang J, Lu Y, Yao Z, Keller ET
Cancer research 2005 Sep 15;65(18):8274-85
Cancer research 2005 Sep 15;65(18):8274-85
Indian hedgehog signaling pathway: expression and regulation in pancreatic cancer.
Kayed H, Kleeff J, Keleg S, Guo J, Ketterer K, Berberat PO, Giese N, Esposito I, Giese T, Büchler MW, Friess H
International journal of cancer 2004 Jul 10;110(5):668-76
International journal of cancer 2004 Jul 10;110(5):668-76
No comments: Submit comment
No validations: Submit validation data